Found: 39
Select item for more details and to access through your institution.
TEACHING CASE STUDIES. Physiologic <sup>18</sup>F-FDG Uptake in Brown Adipose Tissue and Lactating Breast in a Patient with Hodgkin Lymphoma.
- Published in:
- Journal of Nuclear Medicine Technology, 2024, v. 52, n. 2, p. 177, doi. 10.2967/jnmt.123.266472
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1881, doi. 10.3390/cancers16101881
- By:
- Publication type:
- Article
Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 124, doi. 10.1002/ajh.27155
- By:
- Publication type:
- Article
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 160, doi. 10.1111/bjh.19153
- By:
- Publication type:
- Article
Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 4, p. 872, doi. 10.1002/jvc2.205
- By:
- Publication type:
- Article
Physiologic <sup>18</sup>F-FDG Uptake in Brown Adipose Tissue and Lactating Breast in a Patient with Hodgkin Lymphoma.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 4, p. 1, doi. 10.2967/jnmt.123.266472
- By:
- Publication type:
- Article
Disparities in care and outcomes for adolescent and young adult lymphoma patients.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 934, doi. 10.1002/jha2.797
- By:
- Publication type:
- Article
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
- By:
- Publication type:
- Article
DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
- By:
- Publication type:
- Article
Clinical advances in epigenetic therapies for lymphoma.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01452-6
- By:
- Publication type:
- Article
It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy.
- Published in:
- Hematology Reports, 2023, v. 15, n. 1, p. 1, doi. 10.3390/hematolrep15010001
- By:
- Publication type:
- Article
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 12, p. 1863, doi. 10.1007/s11912-022-01330-z
- By:
- Publication type:
- Article
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1845, doi. 10.1007/s11864-022-01035-2
- By:
- Publication type:
- Article
Quality of Life and Survivorship in Lymphoma.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 9, p. 1113, doi. 10.1007/s11912-022-01283-3
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
- Published in:
- 2022
- By:
- Publication type:
- Letter
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
- By:
- Publication type:
- Article
Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 1, p. 89, doi. 10.1007/s11864-021-00935-z
- By:
- Publication type:
- Article
How to Sequence Therapies in Mycosis Fungoides.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cutaneous B-cell pseudolymphoma treated with rituximab and methotrexate.
- Published in:
- Dermatology Online Journal, 2021, v. 27, n. 9, p. 1, doi. 10.5070/D327955138
- By:
- Publication type:
- Article
Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 48, doi. 10.1111/ejh.13609
- By:
- Publication type:
- Article
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 2, p. 1, doi. 10.1007/s11912-020-01011-9
- By:
- Publication type:
- Article
Breast implant‐associated anaplastic large cell lymphoma and the obligation of insurance providers.
- Published in:
- Breast Journal, 2020, v. 26, n. 10, p. 2110, doi. 10.1111/tbj.13893
- By:
- Publication type:
- Article
Glucocorticoid-Induced Hypermetabolism in White Adipose Tissue in Cushing Syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Results from the Colorado Cannabis Users Survey on Health (CUSH), 2016.
- Published in:
- International Journal of Mental Health & Addiction, 2020, v. 18, n. 1, p. 1, doi. 10.1007/s11469-018-0047-x
- By:
- Publication type:
- Article
Phase 1 Study of CA-4948, a Novel Inhibitor of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in Patients with R/R Non-Hodgkin Lymphoma (NHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S256, doi. 10.1016/j.clml.2019.07.168
- By:
- Publication type:
- Article
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
- By:
- Publication type:
- Article
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pitfall of <sup>18</sup>F-FDG PET/CT in Characterization of Relapsed Multisystem Lymphomatoid Granulomatosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta‐analysis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1220, doi. 10.1002/ajh.25226
- By:
- Publication type:
- Article
Qualitative Analysis of Infant Safe Sleep Public Campaign Messaging.
- Published in:
- Health Promotion Practice, 2018, v. 19, n. 2, p. 203, doi. 10.1177/1524839917690339
- By:
- Publication type:
- Article
Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 3, p. 207, doi. 10.1007/s11899-017-0383-0
- By:
- Publication type:
- Article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib ( MLN8237) and Bortezomib in Relapsed Multiple Myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 323, doi. 10.1111/bjh.13765
- By:
- Publication type:
- Article
Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article